Pages that link to "Q40293482"

The following pages link to Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers. (Q40293482):

Displaying 23 items.

• Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices (Q30393322) (← links)
• Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measures (Q33166857) (← links)
• Transperineal vs. transrectal biopsy in MRI targeting (Q33890171) (← links)
• Evaluation of a short RNA within Prostate Cancer Gene 3 in the predictive role for future cancer using non-malignant prostate biopsies (Q36336025) (← links)
• Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005-2013: a population-based analysis (Q38406134) (← links)
• Acknowledging unreported problems with active surveillance for prostate cancer: a prospective single-centre observational study. (Q38583764) (← links)
• ACTIVE SURVEILLANCE FOR PAPILLARY THYROID MICROCARCINOMA: NEW CHALLENGES AND OPPORTUNITIES FOR THE HEALTH CARE SYSTEM (Q38707899) (← links)
• Effect of pathologic revision and Ki67 and ERG immunohistochemistry on predicting radical prostatectomy outcome in men initially on active surveillance. (Q38764526) (← links)
• What is the best way not to treat prostate cancer? (Q38799211) (← links)
• When should active surveillance for prostate cancer stop if no progression is detected? (Q38832126) (← links)
• Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer (Q38924660) (← links)
• Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study. (Q40109539) (← links)
• Active Surveillance in Younger Men With Prostate Cancer. (Q40271880) (← links)
• Long-term follow-up after active surveillance or curative treatment: quality-of-life outcomes of men with low-risk prostate cancer. (Q42287916) (← links)
• Comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillance. (Q47324732) (← links)
• Repeat multiparametric MRI in prostate cancer patients on active surveillance (Q48342579) (← links)
• Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review (Q57106850) (← links)
• The Prognostic PDE4D7 Score in a Diagnostic Biopsy Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes. (Q64964104) (← links)
• Active surveillance outcomes in prostate cancer patients: the use of transperineal template-guided mapping biopsy for patient selection (Q90291482) (← links)
• Personalized schedules for surveillance of low-risk prostate cancer patients (Q90435517) (← links)
• Survey on the practice of active surveillance for prostate cancer from the Middle East (Q91650205) (← links)
• Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs (Q91996112) (← links)
• Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer (Q92438506) (← links)